Armistice Capital LLC Acquires 75,477 Shares of Danaher Corporation $DHR

Armistice Capital LLC lifted its holdings in Danaher Corporation (NYSE:DHR) by 239.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 107,035 shares of the conglomerate’s stock after acquiring an additional 75,477 shares during the period. Armistice Capital LLC’s holdings in Danaher were worth $24,502,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. JPL Wealth Management LLC bought a new position in Danaher during the third quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new stake in shares of Danaher in the second quarter worth approximately $26,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher in the fourth quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher in the 3rd quarter valued at about $27,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher during the 4th quarter worth $27,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

NYSE DHR opened at $177.85 on Thursday. The stock’s fifty day moving average is $180.26 and its two-hundred day moving average is $203.59. The firm has a market capitalization of $125.88 billion, a P/E ratio of 34.40, a price-to-earnings-growth ratio of 2.31 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.88 earnings per share. On average, research analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Analysts Set New Price Targets

Several research analysts have commented on the company. JPMorgan Chase & Co. reduced their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Morgan Stanley dropped their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. UBS Group dropped their target price on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Barclays lowered their price target on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, Guggenheim decreased their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.